SYS-CON MEDIA Authors: RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

ViveBio's Transformational Specimen Storage and Transportation Device, ViveST™, Featured in Presentation at HEP DART 2013

ALPHARETTA, Ga., Dec. 5, 2013 /PRNewswire/ -- ViveBio, LLC announced today that ViveST™, its transformational specimen storage and transportation device, will be featured in a presentation at the 2013 HEP DART conference being held December 8-12, 2013 in Hawaii.  The focus of HEP DART is to gather scientists and researchers to advance knowledge of ongoing drug development processes for Hepatitis B (HBV) and Hepatitis C (HCV).  The presentation entitled, ViveST™ for HBV Testing:  A Transformational Ambient Storage and Transportation Device, will be presented by Daniel McClernon, President and CSO of bioMONTR® Labs (Research Triangle Park, NC).

(Logo: http://photos.prnewswire.com/prnh/20130924/CL84925LOGO )

Infectious disease monitoring often requires collection sites to ship patient samples to reference laboratories, requiring careful temperature control and special packaging.  In the study being presented, HBV positive plasma was loaded onto ViveST™, dried, capped and stored at room temperature.  Results from all studies were compared to those from aliquots of frozen plasma.  The HBV viral load from HBV positive plasma stored on ViveST™ at room temperature up to 60 days was identical to that of frozen plasma.  A linear fit (R2  >0.99) was retained over the course of the 60-day study as indicated by linear regression analysis across all levels and all test points.  This study demonstrates the utility of ViveST™ for transportation and storage of plasma, producing equivalent HBV viral load values with frozen plasma.

The key feature of the ViveST™ is a proprietary absorbent matrix onto which a biological specimen can be loaded by simple pipetting and allowed to dry.  The dried sample can be easily reconstituted into a robust specimen that can be used in multiple downstream applications including RNA/DNA targets, cell recovery, and protein analysis.

ViveST™ is CE marked and has received ANVISA medical device registration in Brazil.  For more information regarding ViveST™ and recent scientific publications and posters, please visit the ViveBio website at www.vivebio.com or contact Timothy Murray at murray@vivebio.com  or Brad Nelson at nelson@vivebio.com or 877-814-7004.

About ViveBio, LLC

ViveBio, LLC is a privately held biotechnology company focused on providing cost-effective solutions for biological specimen transportation and storage.  ViveBio's mission is to expand access to healthcare and extend life through these cost effective solutions and other breakthrough technologies.  The company's initial focus has been to address the need for transporting plasma for quantitative HIV, Hepatitis C and Hepatitis B viral load and genotype tests.  ViveBio's manufacturing and corporate office is located in Alpharetta, Georgia.

SOURCE ViveBio, LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.